4-PREGENEN-11SS-17-21-TRIOL-3, 20-DIONE DERIVATIVES FOR THE TREATMENT OF OCULAR CONDITIONS 4--11SS-17-21--320-

摘要

The present invention relates to pharmaceutical compositions comprising 4-pregenen-11&bgr;-17-21-triol-3,20-dione derivatives, and their use as pharmaceuticals as modulators of the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR). The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat ocular conditions associated with the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR).